期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Advances in the role of circulating tumor cell heterogeneity in metastatic small cell lung cancer
1
作者 qunxia wang Li-Ming Tan 《Cancer Innovation》 2024年第2期1-10,共10页
Small cell lung cancer(SCLC),a highly aggressive malignancy,is rapidly at an extensive stage once diagnosed and is one of the leading causes of death from malignancy.In the past decade,the treatment of SCLC has largel... Small cell lung cancer(SCLC),a highly aggressive malignancy,is rapidly at an extensive stage once diagnosed and is one of the leading causes of death from malignancy.In the past decade,the treatment of SCLC has largely remained unchanged,and chemotherapy remains the cornerstone of SCLC treatment.The therapeutic value of adding immune checkpoint inhibitors to chemotherapy for SCLC is low,and only a few SCLC patients have shown a response to immune checkpoint inhibitors.Circulating tumor cells(CTCs)are tumor cells shed from solid tumor masses into the peripheral circulation and are key to tumor metastasis.Single-cell sequencing has revealed that the genetic profiles of individual CTCs are highly heterogeneous and contribute to the poor outcome and prognosis of SCLC patients.Theoretically,phenotypic analysis of CTCs may be able to predict the diagnostic significance of new potential targets for metastatic tumors.In this paper,we will discuss in depth the heterogeneity of CTCs in SCLC and the value of CTCs for the diagnosis and prognosis of SCLC and as relevant tumor markers in metastatic SCLC. 展开更多
关键词 circulating tumor cell HETEROGENEITY IMMUNOTHERAPY small cell lung cancer tumor micro-environment
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部